Type A - Suzano S.A. (SUZ) 20261031 Stock Analysis

📅 Suzano Key Upcoming Events

• November 05, 2026 Q3 2026 Earnings Release (Confirmed)
  • Description: Suzano has officially scheduled its third-quarter financial results. The release will provide the first consolidated contribution from Arbex, the tissue venture acquired from Kimberly-Clark, and update investors on pulp prices, operating cash generation, leverage, and integration progress.
• November 06, 2026 Q3 2026 Earnings Webcast (Confirmed)
  • Description: Management will discuss quarterly performance, pulp market conditions, the Arbex integration, and capital allocation priorities. Particular attention will center on whether cash generation can support deleveraging following the acquisition.

🏢 Step 1: Suzano Company Overview & Business Model

Q1-A1. What is Suzano?

• Company Name (Ticker): Suzano S.A. (SUZ)
• Sector: Materials
• Exchange: NYSE
• Founded: 1924 (business origins; incorporated December 08, 1987)
• Listing Date: December 10, 2018
• Fiscal Year End: December
• Headquarters: Brazil, São Paulo
• CEO: João Alberto Fernandez de Abreu (Beto Abreu)
• Market Cap: $11.39B
• Shares Outstanding: 1.23B
• Current Stock Price: $9.24
• Annual Dividend Yield: 2.09%
• Ex-dividend Date: May 04, 2026 (ET, historical basis)
• As-of: October 31, 2026 (ET)

Q1-A2. How Does Suzano Make Money?

• Eucalyptus Pulp Manufacturing and Export Sales: Suzano manufactures market pulp primarily from eucalyptus plantations and sells it to paper, tissue, packaging, and specialty-product manufacturers. Revenue depends on shipment volumes, international pulp prices, and foreign exchange movements.
• Integrated Forestry and Industrial Production: The company manages plantations, pulp mills, logistics infrastructure, and energy systems. This integration helps control wood supply, production costs, and export reliability.
• Paper and Packaging Sales: Suzano manufactures printing and writing paper, paperboard, specialty papers, packaging materials, and tissue products for domestic and international customers.
• Global Tissue Expansion: In July 2026, Suzano completed its acquisition of a 51% controlling interest in Arbex, a joint venture with Kimberly-Clark. The venture operates across more than 70 countries and adds consumer and professional tissue manufacturing, brands, and distribution.
• Core Economic Mechanism: Suzano converts competitively produced fiber into globally traded pulp and higher-value paper products. Its investment economics depend heavily on the spread between realized selling prices and production, logistics, financing, and reinvestment costs.

Q1-A3. Suzano’s Revenue Segments & Core Income Sources

• Pulp Segment — 75.5% of Q2 2026 Revenue:
  • Revenue: BRL 8.76B of consolidated BRL 11.59B.
  • Business Significance: Pulp remains the dominant earnings driver. Suzano benefits from substantial eucalyptus-based production capacity and international customer relationships, but commodity pricing and export currency translation create significant volatility.
  • Recent Performance: Pulp revenue declined approximately 15% YoY despite an 8% increase in average USD export pulp prices, reflecting lower sales volumes and BRL appreciation.
• Paper Segment — 24.5% of Q2 2026 Revenue:
  • Revenue: BRL 2.83B.
  • Business Significance: This segment includes paperboard, printing and writing paper, specialty products, and tissue. It provides greater product diversification, though some categories face mature or declining demand.
  • Recent Performance: Revenue declined approximately 6% YoY, while quarterly volumes recovered sequentially.
• Arbex Expansion:
  • Business Scope: The venture includes 22 manufacturing facilities across 14 markets and commercial operations serving more than 70 countries.
  • Financial Contribution: Historical pro forma annual revenue was approximately $3.3B, with adjusted EBITDA around $0.5B, based on the venture’s earlier disclosed transaction scope.
  • Reporting Treatment: Consolidation begins in Q3 2026. These historical pro forma figures are not included in Suzano’s Q2 2026 reported revenue mix and should not be treated as a current-quarter run rate.
• Revenue Concentration: Approximately 80% of Q2 2026 revenue came from export markets, exposing Suzano to international pulp demand and currency movements.

Q1-A4. Who Are Suzano’s Competitors?

• Direct Pulp Competitors:
  • UPM-Kymmene: A major integrated forest-products company with pulp operations and substantial European industrial exposure.
  • Arauco: A significant Latin American pulp producer competing in international markets, including hardwood pulp.
  • CMPC: A diversified Chilean pulp and tissue manufacturer with substantial Latin American exposure.
  • Stora Enso: A European forest-products company with pulp, packaging, and biomaterials operations.
• Paper and Tissue Competitors:
  • International Paper: Competes primarily in fiber-based packaging and related industrial markets rather than identical commodity-pulp exposure.
  • Kimberly-Clark and Other Global Tissue Producers: Compete in selected tissue markets, although Kimberly-Clark also retains a 49% ownership interest in Arbex.
• Competitive Advantages: Suzano’s forestry integration, eucalyptus productivity, industrial scale, logistics infrastructure, and production expertise provide meaningful cost advantages.
• Competitive Limitations: Market pulp is largely commoditized. Even a structurally low-cost producer cannot independently determine global selling prices.
• Industry Position: Suzano is the world’s largest market pulp producer, but production leadership does not translate into monopoly-like pricing power.

Q1-A5. Suzano Key Events: Past 12 Months

• December 10, 2025 Approved Interim Dividends and a Capital Reserve Conversion
  • Description: The board approved interim dividends totaling BRL 1.38B and a BRL 5.00B capital increase funded through existing reserves without issuing additional shares. This reinforced shareholder distributions without creating corresponding equity dilution.
• May 28, 2026 Obtained Competition Approvals for the Kimberly-Clark Tissue Transaction
  • Description: Suzano confirmed that the required competition approvals had been obtained, advancing the transaction toward completion and reducing regulatory uncertainty.
• July 01, 2026 Completed the Acquisition of 51% of Arbex
  • Description: Suzano completed its controlling investment in the international tissue venture with Kimberly-Clark. The transaction broadened its consumer and professional tissue exposure, while introducing integration requirements and additional capital commitments.
• August 12, 2026 Q2 2026 Earnings Release
  • Description: Suzano reported BRL 11.59B in revenue, BRL 4.70B in adjusted EBITDA, and BRL 1.81B in net income. Revenue declined 13% YoY, adjusted EBITDA fell 23%, and USD-denominated net leverage reached 3.4x, underscoring commodity-cycle pressure despite sequential improvements.
• September 2026 Continued Investor Communication on Operational Efficiency and Capital Discipline
  • Description: Management presented its strategic priorities to institutional investors, emphasizing cost competitiveness, tissue diversification, and deleveraging following major investments.

Q1-A6. Step 1 Key Takeaways

• Step 1 Summary: Suzano combines global pulp leadership and an integrated low-cost forestry platform with expanding tissue exposure. However, its cash generation remains sensitive to commodity prices, currency movements, and leverage, while Arbex introduces a potentially important diversification opportunity.

🏰 Step 2: Suzano’s Economic Moat, Growth & Capital Allocation

Q2-A1. Does Suzano Have a Durable Economic Moat?

• Structural Cost Advantage: Suzano’s eucalyptus plantations benefit from favorable growing conditions, industrial scale, forestry research, and integrated logistics. These characteristics support a competitive position that is expensive and time-consuming for new entrants to replicate.
• Entry Barriers: Establishing comparable pulp capacity requires substantial capital investment, suitable land, forestry expertise, environmental approvals, logistics infrastructure, and long development timelines.
• Pricing Power: Suzano has limited direct control over global market pulp prices. Its advantage is primarily the ability to remain competitive during weaker pricing environments rather than consistently increase prices independently.
• Customer Relationships: Industrial buyers value dependable quality, volume, and delivery reliability, but multiple global suppliers limit switching costs.
• Profitability Defense: Company-reported LTM ROIC was 10.3% in Q2 2026, down 2.8 percentage points YoY. The decline illustrates that cost advantages do not fully insulate returns from the commodity cycle.
• Moat Assessment: Suzano possesses a meaningful production-cost moat, but not the pricing autonomy or recurring-revenue economics associated with the strongest consumer or software franchises.

Q2-A2. Is Suzano’s Growth Sustainable?

• Industry Structure and Outlook: Global pulp demand benefits from tissue consumption, hygiene products, packaging, and emerging-market income growth. These structural drivers are offset by mature printing-paper demand and periodic additions to global pulp supply.
• Growth Sustainability: Suzano’s growth opportunity depends on absorbing newer pulp capacity, improving product mix, expanding tissue operations, and maintaining cost leadership. Growth is capital-intensive and cannot be evaluated independently of returns on incremental investments.
• Downside Scenarios:
  • 1 Global Pulp Oversupply: New capacity enters the market faster than demand expands, depressing benchmark prices and limiting Suzano’s ability to monetize higher production volumes.
  • 2 Prolonged Chinese Demand Weakness: Slower industrial activity and paper consumption in China reduce pulp purchases and pressure export prices.
  • 3 Arbex Integration Underperformance: Difficulties integrating international manufacturing and distribution operations delay expected efficiencies while increasing financing and working-capital requirements.

Q2-A3. How Does Suzano Allocate Capital & Return Cash?

• Reinvestment Strategy: Suzano historically directed substantial capital toward industrial capacity, forestry assets, productivity improvements, and major projects such as the Cerrado pulp mill.
• Acquisition Strategy: The Arbex transaction increases downstream tissue exposure and establishes a broader international platform, potentially reducing dependence on standalone pulp markets over time.
• Financial Discipline: Net debt/adjusted EBITDA reached 3.4x on the company’s USD basis at Q2 2026. Management has emphasized deleveraging rather than aggressive additional expansion.
• Shareholder Returns: Suzano distributes dividends and has historically repurchased shares, but capital requirements and leverage limit the predictability of shareholder distributions.
• Capital Allocation Assessment: Expansion has strengthened industrial scale, yet the economic returns from large investments remain exposed to pulp cycles. Future value creation depends on converting completed capacity and acquisitions into sustainable free cash flow.

Q2-A4. Step 2 Key Takeaways

• Scoring Rationale:
  • Economic Moat (8/10): Integrated forestry, global scale, and competitive production economics provide substantial barriers, although commodity pricing limits independent pricing power.
  • Growth Sustainability (6/8): Tissue demand and geographic diversification support expansion, while cyclical pulp markets and new supply limit visibility.
  • Capital Allocation (5/7): Strategic investments expand the earnings base, but leverage and capital intensity constrain near-term flexibility.
• 📊 Step 2 Score: 19/25 pts (Economic Moat 8/10 + Growth Sustainability 6/8 + Capital Allocation 5/7)
• Step 2 Summary: Suzano’s competitive advantage is principally cost-based and supported by industrial scale. Long-term growth remains attractive but requires disciplined capital deployment and sustained deleveraging.

💰 Step 3: Is Suzano Profitable? Financial Health Analysis

Q3-A1. Suzano’s Growth & Profitability Trends

• Revenue Declined Despite Sequential Recovery: Q2 2026 net revenue was BRL 11.59B, down 13% YoY but up 6% QoQ. TTM revenue through June 2026 was BRL 47.83B, compared with BRL 50.12B in FY2025 and BRL 47.40B in FY2024.
• Operating Earnings Contracted: TTM operating income declined to BRL 8.34B from BRL 10.08B in FY2025 and BRL 14.59B in FY2024. The corresponding operating margins were approximately 17.4%, 20.1%, and 30.8%, demonstrating considerable deterioration from the stronger 2024 environment.
• Reported Net Income Remains Volatile: Q2 2026 net income was BRL 1.81B versus BRL 5.01B in Q2 2025. TTM net income was approximately BRL 8.17B, with reported EPS of BRL 6.60, compared with FY2025 EPS of BRL 10.82 and an FY2024 loss of BRL 5.59 per share.
• Free Cash Flow Remains Positive: On a standardized operating cash flow less capital expenditure basis, TTM FCF was approximately BRL 5.00B, compared with BRL 5.66B in FY2025 and BRL 4.23B in FY2024.
• Operating Leverage Is Negative on the YoY Comparison: Q2 adjusted EBITDA declined 23% despite revenue declining 13%. The adjusted EBITDA margin fell from approximately 46% to 41%, reflecting reduced operating leverage during a weaker volume and currency environment.

Q3-A2. How Profitable Is Suzano? (Margins & ROIC)

• Reported ROIC: Suzano reported LTM ROIC of 10.3% at Q2 2026, down from approximately 13.1% one year earlier.
• Standardized ROIC: A separately standardized financial-data calculation indicates approximately 4.5% ROIC. The difference reflects accounting definitions and capital-base adjustments, meaning the two figures should not be treated as interchangeable.
• Cost of Capital: A standardized WACC estimate is approximately 4.3%, implying a narrow ROIC spread on that particular basis. A separate economic assessment using a higher risk-adjusted USD hurdle rate would imply less favorable excess returns.
• Margins: Q2 2026 adjusted EBITDA margin was approximately 41%, compared with 46% a year earlier. High EBITDA margins coexist with substantial depreciation, financial costs, and reinvestment requirements.
• Peer Context: Suzano’s integrated eucalyptus operations provide competitive production economics, but reported returns remain sensitive to pricing cycles and the capital committed to industrial assets.
• Profitability Assessment: The company is operationally profitable, although its latest returns do not establish consistently superior capital efficiency across the full cycle.

Q3-A3. What Drives Suzano’s Returns? (ROIC Breakdown)

• Selected Efficiency Indicators: Pulp Cash Production Cost, Production and Sales Volume, and Inventory Turnover — these indicators capture the relationship between manufacturing efficiency, utilization, working capital, and Suzano’s asset-heavy return structure.
  • Pulp Cash Production Cost: Q2 2026 production cash cost excluding downtime was BRL 843 per tonne, approximately 1% higher YoY. Cost discipline helped mitigate inflationary pressure but did not fully offset weaker revenue realization.
  • Production and Sales Volume: Pulp sales declined 11% YoY to 2.90 million tonnes in Q2 2026, reducing operating leverage. Total pulp and paper shipments reached 3.30 million tonnes, down approximately 10% YoY.
  • Inventory Turnover: Standardized TTM inventory turnover was approximately 3.93x, compared with 4.21x in FY2025, indicating slower capital recycling through inventories.
• Operational Driver: The combination of utilization, realized pulp prices, and cash production costs determines how effectively Suzano converts its large fixed-asset base into operating earnings.
• Return Driver Conclusion: Lower shipment volumes and compressed margins reduce capital productivity even when per-tonne manufacturing costs remain relatively stable.

Q3-A4. Are Suzano’s Earnings High Quality?

• Operating Cash Conversion: TTM operating cash flow through June 2026 was approximately BRL 16.66B against standardized net income of approximately BRL 8.20B, giving OCF/net income of approximately 2.03x.
• Free Cash Flow Conversion: Standardized TTM FCF of approximately BRL 5.00B represents around 61% of standardized net income, as substantial reinvestment absorbs operating cash.
• Accounting Considerations: Depreciation, currency effects, hedging, financial results, and other noncash adjustments can create large differences between reported net income and actual cash generation.
• Quality Assessment: Operating cash flow provides evidence of genuine earnings conversion, but commodity-sensitive cash generation and high capital requirements weaken the predictability of distributable free cash flow.

Q3-A5. Is Suzano’s Balance Sheet Healthy? (Debt & Leverage)

• Cash and Investments: At June 2026, cash and short-term investments were approximately BRL 26.27B.
• Total Debt: Approximately BRL 99.41B, producing net debt of approximately BRL 73.14B on the standardized consolidated balance-sheet basis.
• Leverage: Management reported USD-based net debt/adjusted EBITDA of 3.4x at Q2 2026, up from 3.1x one year earlier. A standardized trailing EBITDA calculation gives approximately 3.68x.
• Liquidity: The current ratio was approximately 3.38x, suggesting meaningful current-asset coverage of short-term liabilities.
• Interest Coverage: Standardized EBIT/interest expense was approximately 1.31x, a relatively narrow accounting coverage margin.
• Financial Assessment: Suzano has significant liquidity and continuing operating cash generation, but debt remains substantial compared with sustainable earnings. Refinancing, currency movements, and capital commitments warrant continued monitoring.

Q3-A6. Step 3 Key Takeaways

• Scoring Rationale:
  • Profitability·Capital Efficiency (7/10): Large operating earnings and production efficiency support profitability, although ROIC and margins have deteriorated.
  • Cash Flow·Profit Quality (6/8): Operating cash generation exceeds net income, but heavy reinvestment limits free cash flow conversion.
  • Financial Soundness·Debt Management (4/7): Liquidity is meaningful, but net leverage above 3x and modest accounting interest coverage constrain financial flexibility.
• 📊 Step 3 Score: 17/25 pts (Profitability·Capital Efficiency 7/10 + Cash Flow·Profit Quality 6/8 + Financial Soundness·Debt Management 4/7)
• Step 3 Summary: Suzano remains profitable and cash-generative, but weaker margins and elevated leverage constrain its financial resilience. Deleveraging is a central determinant of future equity value.

🔎 Step 4: Suzano Forensic Accounting & Dilution Review

Q4-A1. Does Suzano Have Accounting Red Flags?

• Revenue recognition: Not found.
  • Evidence: The reviewed interim statements report sales across pulp and paper operations, with identifiable shipment volumes and product revenue. No material revenue-recognition irregularity was established from the reviewed disclosures.
• Cost capitalization: Not found.
  • Evidence: Extensive forestry and industrial investments are capitalized under applicable accounting rules. Their scale requires monitoring depreciation, impairment assumptions, and whether recurring maintenance spending is adequately reflected in cash-flow analysis.
• Sharp increase in accounts receivable and inventory: Not found.
  • Evidence: TTM operating cash flow includes a positive receivables movement of approximately BRL 906M and an inventory-related cash outflow of approximately BRL 176M. These figures do not independently establish abnormal receivables accumulation.
• Non-recurring adjustment (normalization): Discovered.
  • Evidence: Currency-related financial results, derivatives, tax-related adjustments, asset disposals, and other nonrecurring items can materially affect IFRS net income and adjusted EBITDA comparisons. Reported earnings require normalization when assessing sustainable operating value.

Q4-A2. Is Suzano Overspending? (Capex & Capital Cycle)

• Capital Expenditure Cycle: TTM cash capital expenditures were approximately BRL 11.67B, following BRL 16.37B in FY2024 and BRL 17.45B in FY2023.
• Industry Oversupply Risk: Large global pulp projects can add substantial supply before demand fully absorbs the capacity. New production therefore may pressure prices even when individual mills operate efficiently.
• Company-Specific Exposure: Suzano has completed substantial capacity investment, shifting the near-term priority from construction to utilization, operating efficiency, and cash recovery.
• Assessment: Lower capex improves prospective free cash flow, but additional capacity can weaken the industry price environment. The investment cycle remains a material fundamental consideration.

Q4-A3. How Sound Is Suzano’s Cash Flow?

• Operating Cash Flow: TTM OCF of BRL 16.66B remained positive but declined approximately 17.7% on the standardized trailing comparison.
• Capital Expenditure: TTM capex was approximately BRL 11.67B, absorbing about 70% of operating cash flow.
• Free Cash Flow: Standardized FCF was approximately BRL 5.00B, providing a positive but narrower cash cushion for dividends, debt reduction, and acquisitions.
• Warning Signals: The principal concern is declining cash generation alongside substantial leverage, rather than sustained negative operating cash flow.
• Assessment: Cash flow is operationally supported, yet its sensitivity to pulp prices and investment requirements makes sustained deleveraging dependent on market conditions.

Q4-A4. Is Suzano Diluting Shareholders?

• ⏪ Confirmed (Past) Dilution: Shares outstanding declined approximately 0.35% YoY to 1.23B. Historical repurchases have offset some equity issuance, while the December 2025 reserve capitalization did not involve new shares.
• ⏩ Potential (Future) Dilution & Overhang: Equity-linked compensation and corporate share issuance require monitoring, but no large imminent issuance or refinancing-driven equity offering was established in the reviewed disclosures. The greater immediate shareholder concern is financial leverage rather than substantial dilution.

Q4-A5. Data Integrity Check

• Period: FY2025 annual figures, TTM June 2026 financials, and Q2 2026 quarterly results are explicitly separated ➡ (Pass)
• Definition: IFRS reported net income, standardized cash flows, company-adjusted EBITDA, and distinct ROIC methodologies are identified rather than conflated ➡ (Pass)
• Number of Shares: Approximately 1.23B current ADS-equivalent shares are distinguished from weighted-average EPS denominators; the current ADR ratio is one ordinary share per ADS ➡ (Pass)
• Unit: USD stock valuation and BRL reporting figures are separated using the applicable currency and reporting period ➡ (Pass)
• Single Value Confirmation: Reported figures retain their original definitions, while standardized metrics are used consistently for historical comparisons ➡ (Pass)

Q4-A6. Step 4 Key Takeaways

• Scoring Rationale:
  • Accounting anomalies·distortion signals (6/8): No verified major reporting irregularity emerged, but financial adjustments and asset accounting complicate earnings interpretation.
  • Cash flow warning signals (5/7): Cash generation remains positive, although lower OCF and substantial reinvestment reduce flexibility.
  • Dilution factors (5/5): Share count has modestly decreased and no material imminent dilution event was identified.
• 📊 Step 4 Score: 16/20 pts (Accounting anomalies·distortion signals 6/8 + Cash flow warning signals 5/7 + Dilution factors 5/5)
• Step 4 Summary: Suzano’s primary forensic concerns involve capital intensity, cash-flow sustainability, and earnings normalization rather than demonstrated accounting misconduct or major shareholder dilution.

👔 Step 5: Suzano Management & Shareholder Alignment

Q5-A1. Can You Trust Suzano’s Management? (Guidance Track Record)

• Management Execution: Suzano has completed substantial industrial investment and expanded internationally through the Arbex acquisition.
• Operating Discipline: Q2 2026 production cash cost excluding downtime increased only approximately 1% YoY despite industry cost pressures.
• Guidance Reliability: Management has consistently emphasized cost competitiveness and deleveraging, but weaker YoY profitability demonstrates that strategic execution cannot eliminate commodity-cycle exposure.
• Transparency: Quarterly disclosures provide detailed volume, price, cost, cash-generation, and leverage indicators, supporting operational monitoring.
• Assessment: Management demonstrates operating expertise, although the success of recently completed investments and the tissue acquisition remains to be established through consolidated results.

Q5-A2. What Are Suzano Insiders Doing?

• Recent Insider Filings: October 16, 2026 Form 4 records included Douglas Seibert Lazaretti, Executive Vice President of Forestry, and other reporting insiders. These included holdings disclosures rather than identified open-market purchases or sales.
• Open-Market Activity: Available dedicated insider-filing records identified zero open-market purchase shares and zero open-market sale shares in the most recent six-month transaction window, for net open-market activity of zero shares.
• Management Ownership: Reported insider ownership was approximately 18.11%, although this includes broader insider holdings and should not be interpreted as direct personal ownership by the CEO.
• Sentiment Assessment: The absence of a verified open-market buying cluster provides no strong positive insider signal. Holdings disclosures and equity awards should not automatically be interpreted as discretionary management trades.

Q5-A3. Is Suzano’s Management Aligned With Shareholders?

• Shareholding Structure: Suzano is listed on Brazil’s Novo Mercado segment, which provides governance protections associated with a single ordinary-share structure.
• Ownership Alignment: Material insider and controlling-shareholder exposure creates economic incentives to preserve long-term enterprise value.
• Compensation: Performance-related equity incentives can support alignment, but the precise relationship between executive compensation and per-share capital returns is less transparent than the company’s operating KPIs.
• Capital Allocation Accountability: With substantial debt and investment requirements, management should be evaluated on sustainable ROIC, free cash flow, and net leverage rather than industrial capacity growth alone.
• Governance Assessment: Governance foundations are reasonably strong, but acquisition discipline and capital-return efficiency remain essential tests.

Q5-A4. Step 5 Key Takeaways

• Scoring Rationale:
  • Management Trust (4/5): Strong operating expertise and disclosure quality support credibility, although major investments have not yet delivered consistently strong incremental returns.
  • Insider Trends (3/5): Meaningful insider ownership supports alignment, but no confirmed discretionary buying cluster strengthens near-term confidence.
  • Governance·Compensation System (3/5): The governance structure is supportive, while stronger evidence of compensation tied to sustainable per-share value would improve confidence.
• 📊 Step 5 Score: 10/15 pts (Management Trust 4/5 + Insider Trends 3/5 + Governance·Compensation System 3/5)
• Step 5 Summary: Suzano’s management has substantial operating expertise and reasonable governance alignment. The decisive test is whether capital deployment produces improving returns and leverage reduction.

⛵ Step 6: Suzano Market Flow & Sentiment

Q6-A1. Analyst Consensus vs Suzano Guidance

• Analyst Expectations: The compiled analyst outlook is positive, with a current consensus price target near $12.38 and a forward P/E of approximately 6.99x.
• Guidance Comparison: Suzano principally communicates operating indicators, investment requirements, and leverage objectives rather than a directly comparable comprehensive USD EPS guidance midpoint. Therefore, a precise company-guidance-versus-consensus EPS gap cannot be established.
• Fundamental Sentiment: Q2 2026 results showed sequential improvement in EBITDA but a material YoY decline. The market’s positive forward valuation outlook implicitly depends on better cash generation, pulp-market stabilization, and Arbex execution.
• Revision Evidence: A consistent numerical 90-day history of estimate revisions was not established. Current consensus levels should not be described as proven upward revisions.

Q6-A2. What Is Suzano’s Short Interest?

• Institutional Ownership: Approximately 29.46% of outstanding shares were reported as institutionally held.
• Short Interest: Approximately 10.09M shares were sold short, representing about 0.97% of total shares outstanding.
• Days-to-Cover: Approximately 3.71 trading days.
• Recent Direction: Reported short interest declined from approximately 11.44M shares in the preceding month.
• Market Interpretation: The short position is modest relative to the total share base, suggesting limited evidence of concentrated bearish positioning or an imminent short squeeze. A verified short percentage of the free float was unavailable.

Q6-A3. Step 6 Key Takeaways

• Scoring Rationale:
  • Consensus vs Guidance (2/3): Positive analyst expectations are supported by potential earnings recovery, though direct EPS guidance comparison is unavailable.
  • Supply·Short Interest (1/2): Modest short interest is supportive, but institutional positioning does not establish a strong accumulation trend.
• 📊 Step 6 Score: 3/5 pts (Consensus vs Guidance 2/3 + Supply·Short Interest 1/2)
• Step 6 Summary: Market sentiment is moderately constructive, with limited short pressure. However, the equity remains sensitive to operating performance rather than positioning-driven catalysts.

🚀 Step 7: Suzano Catalysts & Price Triggers

Q7-A1. What Could Move Suzano Stock? (Top 3 Catalysts)

• 1 Arbex Consolidation and International Tissue Expansion
  • Timing: Q3 2026 results on November 05, 2026 and subsequent quarterly reporting.
  • Success Conditions: Consolidated results demonstrate meaningful tissue earnings, manageable integration costs, and progress toward operating efficiencies.
  • Failure Risk: Integration expenses, weak tissue margins, or additional capital requirements offset expected diversification benefits.
• 2 Pulp Price and Shipment Recovery
  • Timing: Over the next 6-12 months, beginning with the Q3 2026 earnings release.
  • Success Conditions: Export pulp prices stabilize or improve, volumes recover, and production cash costs remain controlled.
  • Failure Risk: New industry capacity and weak Asian demand sustain low prices despite stable production costs.
• 3 Deleveraging and Free Cash Flow Expansion
  • Timing: Through the 2027 quarterly reporting cycle.
  • Success Conditions: Operating cash flow improves while capital expenditure remains below the major expansion-phase peak, reducing net leverage.
  • Failure Risk: Commodity weakness, foreign exchange movements, or acquisition-related cash needs delay the reduction in debt.

Q7-A2. Suzano’s Earnings Revision Trend

• Current Forward Expectations: The compiled forward P/E of approximately 6.99x indicates that investors and analysts expect material earnings generation relative to the current equity value.
• Recent Operating Evidence: Q2 2026 adjusted EBITDA improved 3% QoQ but declined 23% YoY, producing mixed signals for near-term earnings estimates.
• Revision Visibility: A complete, comparable 90-day EPS revision series was not established. Accordingly, the latest operating recovery cannot be described as a confirmed positive consensus revision cycle.
• Next Revision Catalyst: Q3 2026 earnings will be particularly important because they incorporate the beginning of Arbex consolidation.

Q7-A3. Step 7 Key Takeaways

• Scoring Rationale:
  • Catalyst (6/7): Arbex consolidation, potential pulp recovery, and deleveraging are identifiable catalysts, with the first supported by a confirmed reporting milestone.
  • EPS Trend (2/3): Sequential operating improvement supports potential stabilization, but a verified sustained upward EPS revision trend is absent.
• 📊 Step 7 Score: 8/10 pts (Catalyst 6/7 + EPS Trend 2/3)
• Step 7 Summary: Suzano has tangible opportunities for improving market perception through diversification and stronger cash generation. Their significance depends on observable execution rather than announcements alone.

⚖️ Step 8: Is Suzano Fairly Valued? Valuation Analysis

Q8-A1. Suzano’s Key Valuation Multiples

• PE Ratio: 7.62x (undervalued) — low headline earnings multiple, though financial and currency effects can distort sustainable profits.
• PS Ratio: 1.23x (fairly valued) — modest equity valuation relative to revenue, but significant financial leverage must be considered.
• PB Ratio: 1.18x (fairly valued) — near book value, with asset-heavy returns and cycle exposure limiting its standalone meaning.
• P/TBV Ratio: 1.59x (fairly valued) — a moderate premium to tangible equity for a globally scaled industrial producer.
• P/FCF Ratio: 12.40x (fairly valued) — positive standardized cash generation supports equity value, but capital expenditure remains substantial.
• P/OCF Ratio: 3.72x (undervalued) — reflects strong operating cash generation before major capital spending.
• EV/Sales Ratio: 2.70x (fairly valued) — enterprise valuation reflects substantial debt relative to equity value.
• EV/EBITDA Ratio: 6.49x (fairly valued) — modest for a cost-competitive producer, but appropriate consideration must be given to cyclicality and leverage.
• EV/EBIT Ratio: 15.46x (fairly valued) — depreciation and asset intensity substantially affect valuation below EBITDA.
• EV/FCF Ratio: 27.09x (overvalued) — enterprise valuation is demanding relative to post-capex cash generation.
• Forward PE: 6.99x (undervalued) — suggests low valuation against expected earnings, subject to forecast sustainability.
• PEG Ratio: N/A (unverifiable)
• Scoring Rationale: Equity multiples indicate potential undervaluation, while enterprise-value and post-capex measures offer a more restrained interpretation. A moderate positive adjustment recognizes the low equity price without ignoring debt and reinvestment requirements.
• 📌 (1) Axis Q8-A1 Score: +2

Q8-A2. Suzano vs Peers: Valuation Comparison

• Multiple selection based on peer comparison: EV/EBITDA is the preferred comparison because it incorporates debt and compares operating earnings before depreciation. Relevant peers include UPM, CMPC, and Stora Enso, although differences in paper, packaging, and forestry exposure complicate comparability.
• Calculation of peer-to-peer deviation rate: Unverifiable on a consistent current-period, same-definition peer sample.
  • 🧮 Calculation Formula: ((Suzano EV/EBITDA 6.49x - verified peer mean) / verified peer mean) × 100; a numerical result cannot be established without a reconciled peer mean.
• Scoring Rationale: Suzano’s operating and financial structure warrants comparison with integrated forest-products producers rather than broad industrial peers. A reliable matched peer average was not established, so a numerical discount or premium cannot be assigned.
• 📌 (2) Axis Q8-A2 Score: 0

Q8-A3. Is Suzano Cheap or Expensive vs Its History?

• Comparison Indicators: Historical EV/EBITDA based on five consecutive fiscal-year-end observations from FY2021 through FY2025, with the current October 2026 value assessed separately.
  • Historical Observations: FY2021 6.21x; FY2022 4.54x; FY2023 7.68x; FY2024 6.56x; FY2025 6.67x.
  • Sample: Five annual fiscal-year-end observations spanning four years.
  • Minimum: 4.54x.
  • Maximum: 7.68x.
  • Current: 6.49x.
  • Range Position Formula: (6.49 - 4.54) / (7.68 - 4.54) × 100 = 62.1%.
• Scoring Rationale: Suzano trades in the upper portion of the observed annual-endpoint valuation range despite its low headline P/E. The comparison indicates a modest historical valuation premium on an enterprise basis, not a clearly depressed-cycle multiple. The result describes the sampled annual observations rather than every valuation reached during the period.
• 📌 (3) Axis Q8-A3 Score: -2

Q8-A4. What Growth Is Priced Into Suzano? (Reverse DCF)

• Implied Growth Rate: 3.3%
  • 1 Methodology: Illustrative 10-year enterprise reverse DCF using starting normalized unlevered free cash flow of $1.55B and current enterprise value of approximately $24.88B. The model solves for constant annual FCFF growth required to reproduce the enterprise valuation.
  • 2 Core assumptions: Analyst-estimated starting FCFF of $1.55B, 9.0% USD nominal WACC, 2.0% terminal growth, and a 10-year explicit forecast period. Starting FCFF is a normalized analytical estimate, not the company’s reported operating cash flow less capex; it incorporates assumptions for after-tax operating earnings, maintenance investment, and working capital before financing.
• Achievable Growth Rate: 3.0%
  • Basis: A conservative analytical scenario assumes modest long-term pulp demand growth, additional contribution from tissue operations, and gradual improvement in capacity utilization, offset by commodity pricing volatility and ongoing reinvestment.
• Growth gap and difficulty assessment:
  • 🧮 Formula: Achievable Growth Rate 3.0% - Implied Growth Rate 3.3% = -0.3%p
• Scoring Rationale: The model suggests that the current enterprise value requires moderate growth, broadly consistent with a conservative operating scenario. However, changes in normalized FCFF, discount rates, pulp prices, and terminal assumptions materially influence the implied result.
• 📌 (4) Axis Q8-A4 Score: 0

Q8-A4-1. What Growth Hurdle Does the Market Demand From Suzano? (Reverse DCF Alternative)

• Scoring Rationale: Not applicable — a simplified enterprise reverse DCF can be constructed using Suzano’s operating cash generation, reinvestment requirements, and explicit normalized FCFF assumptions.
• 📌 (4) Axis Q8-A4-1 Score: ➖

Q8-A5. Suzano’s Hidden Asset & Stake Valuation

• Scoring Rationale: Not applicable — Suzano’s forestry and industrial assets primarily support its operating business, while the acquired Arbex controlling stake is integrated into the future operating valuation; a separately realizable qualifying asset value of at least 10% of market capitalization cannot be established without double counting.
• 📌 (5) Axis Q8-A5 Score: ➖

Q8-A6. Final Valuation Adjustment

• Scoring Rationale: A modest negative adjustment reflects the transition created by Arbex consolidation, including acquisition accounting, minority interests, and integration costs not fully captured in pre-consolidation operating metrics. The acquisition adds diversification, but its incremental economic returns remain uncertain.
• 📌 (6) Axis Q8-A6 Score: -1

Q8-A7. Valuation Adjustment Score Calculation

• Calculation Process:
  • (1) Axis (Key Valuation Indicators): +2 pts (Undervalued)
  • (2) Axis (Peer-to-peer deviation rate): 0 pts (Peer deviation unverified)
  • (3) Axis (Historical Band Position): -2 pts (observed-range position p = 62.1%; Overvalued)
  • (4) Axis (Justification for Growth): 0 pts (Reverse DCF growth gap -0.3%p)
  • (5) Axis (Held assets·Share Valuation): 0 pts (Not applicable)
  • (6) Axis (Final adjustment): -1 pts (Acquisition consolidation uncertainty)
• 📊 Valuation Adjustment Score: A1 (+2) + A2 (0) + A3 (-2) + A4 (0) + A5 (0) + A6 (-1) = -1 pts
• Commentary: Suzano’s low equity valuation offers some attraction, but enterprise valuation is less compelling when leverage, capital intensity, and historical trading ranges are considered.
• Step 8 Summary: The stock appears reasonably valued with pockets of equity-level upside. Stronger evidence of sustainable free cash flow and declining debt would improve confidence in its valuation.

💀 Step 9: What Are the Risks of Suzano? Fatal Risks & Pre-Mortem

Q9-A1. What Are the Biggest Risks to Suzano?

• 1 Prolonged pulp price weakness and excess capacity:
  • Cause: Global producers expand supply while major consuming markets experience weak demand or inventory normalization.
  • Impact: Suzano’s high fixed-cost industrial base creates sensitivity to pulp prices and volumes. Q2 2026 revenue declined 13% YoY while adjusted EBITDA fell 23%, illustrating operating earnings sensitivity.
  • Mitigation/Monitoring Indicators: Monitor pulp export prices, quarterly shipment volumes, adjusted EBITDA per tonne, production costs, and industry capacity additions.
• 2 Elevated leverage and financing pressure:
  • Cause: Major investments, acquisitions, and cyclical operating earnings create substantial financial obligations.
  • Impact: USD-based net leverage of 3.4x at Q2 2026 reduces flexibility and could slow debt reduction if cash generation remains weak.
  • Mitigation/Monitoring Indicators: Track net debt/adjusted EBITDA, liquidity, interest coverage, refinancing terms, and free cash flow after capex.
• 3 Arbex integration and consolidation complexity:
  • Cause: Suzano must integrate international tissue assets, brands, production facilities, and distribution operations while managing a minority shareholder relationship.
  • Impact: Higher integration expenses or weaker tissue margins could reduce acquisition returns and delay deleveraging.
  • Mitigation/Monitoring Indicators: Review Arbex’s consolidated revenue, EBITDA, working capital, integration spending, and minority-interest allocation.

Q9-A2. How Sensitive Is Suzano to the Economy?

• 1 Stronger Brazilian Real Against the US Dollar (Negative Impact ⬇): A stronger BRL reduces the translated value of USD-linked export revenue and can compress operating margins if local costs do not decline proportionately.
• 2 Lower Global Pulp Prices (Negative Impact ⬇): Lower benchmark selling prices reduce revenue per tonne and weaken EBITDA and operating cash generation against a substantial fixed-cost base.
• 3 Higher Global Interest Rates (Negative Impact ⬇): Higher refinancing costs can increase cash interest expense and reduce financial flexibility while net debt remains elevated.

Q9-A3. Suzano Pre-Mortem: What Could Go Wrong?

• 1 A prolonged global pulp downturn overwhelms Suzano’s cost advantage: New capacity and weak Chinese demand push pulp prices materially lower, reducing EBITDA and forcing another period of weak cash conversion.
  • Early Warning Signal: Multiple quarters of lower realized pulp prices accompanied by declining adjusted EBITDA per tonne and stagnant shipments.
• 2 Leverage remains elevated despite declining capital expenditure: Cash generation weakens while acquisition costs and financing needs remain substantial, delaying debt reduction and reducing shareholder distributions.
  • Early Warning Signal: USD net debt/adjusted EBITDA rises materially above the Q2 2026 level of 3.4x while recurring FCF declines.
• 3 Arbex fails to deliver its expected diversification benefits: International tissue operations face integration inefficiencies, margin pressure, and working-capital demands, reducing returns on the acquisition.
  • Early Warning Signal: Consolidated tissue EBITDA and cash conversion fall below reasonable operating assumptions for multiple reporting periods.

Q9-A4. Risk Adjustment Score

• Reason for Scoring: Suzano faces an ongoing, quantitatively demonstrated operating exposure: Q2 2026 revenue declined 13% YoY, adjusted EBITDA fell 23%, and operating cash generation declined approximately 30%, while USD net leverage increased to 3.4x from 3.1x one year earlier. These trends create continuing pressure on debt reduction and cash-flow resilience. Substantial liquidity, positive operating cash flow, integrated production economics, and reduced expansion-phase capex mitigate the risk of severe financial distress.
• 📊 Risk Adjustment Score: -7 pts
• Step 9 Summary: Suzano’s most significant risks are cyclical earnings deterioration and the resulting pressure on an already leveraged balance sheet. The company retains meaningful defenses, but its investment outcome remains highly dependent on cash generation.

🎯 Step 10: Suzano Final Verdict: Score & Rating

Q10-A1. Investment Score & Rating

• Investment Score Calculation Formula:
  • Step breakdown: S2 (19) + S3 (17) + S4 (16) + S5 (10) + S6 (3) + S7 (8) = 73 pts
  • Steps 2-7 Sum (73 pts) + Valuation Adjustment (-1 pts) + Risk Adjustment (-7 pts) = Investment Score 65 pts
• Investment Score & Rating: 65 pts (B Rating ⭐⭐⭐)
  • Commentary: Suzano’s cost-competitive production platform, operating cash generation, and international tissue expansion support its fundamental investment case. However, leverage, earnings volatility, and limited valuation protection restrain the overall assessment.

Q10-A2. Should You Buy Suzano? (Recommendation)

• Recommendation: Hold
  • Commentary: Suzano offers exposure to a potential pulp-cycle recovery and greater downstream diversification through Arbex. Existing holders can reasonably monitor operating improvements, but the combination of financial leverage and commodity sensitivity favors disciplined entry pricing over aggressive accumulation.

Q10-A3. Investment Thesis in One Line

• Suzano’s global pulp cost leadership and expanding tissue business offer cyclical recovery potential, but elevated leverage and volatile commodity pricing constrain the margin of safety.

Q10-A4. Suzano’s Price Trend & Key Drivers

• Stock Price Trend Over the Past 12 Months: Sideways With a Recent Recovery ➡️📈 — SUZ gained approximately 0.9% over the trailing year, trading within a 52-week range of $7.56–$11.54. The October 30, 2026 close of $9.24 was above the 50-day moving average of approximately $8.85 and the 200-day moving average of approximately $9.03.
• October 26, 2026 Late-October Recovery in Trading Demand
  • Description: Shares began a notable advance ahead of the scheduled Q3 earnings release, amid renewed attention to Suzano’s pulp and tissue outlook.
  • Stock Price Reaction: Upward 📈 — SUZ increased from $8.64 on October 23 to $9.24 on October 30, a gain of approximately 6.9% over five trading sessions. The advance preceded the earnings release, so it should not be attributed to results that had not yet been published.

Q10-A5. Action Plan

• Current Price: $9.24
• Buy Zone: $8.50 ($8.20–$8.80)
  • (1) Calculation of Fundamental Value: A conservative entry range below the current market price provides additional protection against pulp price volatility, leverage, and uncertainty surrounding Arbex consolidation.
  • (2) Momentum Premium/Discount Application: Recent price improvement does not independently establish a durable earnings recovery. No substantial momentum premium is warranted until stronger operating cash generation and debt reduction are demonstrated.
  • (3) Conclusion: An entry band of $8.20–$8.80, centered at $8.50, provides a more disciplined risk-reward profile while remaining above the lower end of the recent annual trading range.
• Price Target: $10.82
• Expected Return: +17.1% (vs. current price)
  • 📍 Selected Valuation Metric: Normalized forward EV/EBITDA — a 7.0x enterprise multiple applied to analyst-estimated next-12-month consolidated EBITDA of $3.83B, followed by an equity bridge using estimated net debt and ADS-equivalent shares.
  • 🧮 Price Target Calculation Formula: (($3.83B × 7.0x) - $13.50B net debt) / 1.23B shares = $10.82
  • ⚓ Valuation Basis and Key Assumptions: The analytical EBITDA assumption incorporates a moderate contribution from Arbex, broadly stable pulp pricing, and operating efficiencies, rather than a return to peak-cycle margins. The 7.0x target multiple is a judgment-based modest premium to Suzano’s current 6.49x EV/EBITDA, supported by potential diversification but constrained by leverage and capital intensity. This differs from the current historical-band comparison because the forward valuation includes tissue consolidation and potential cash-generation recovery, rather than solely the pre-consolidation trailing earnings base. The estimate uses $13.50B of net debt as a starting equity bridge and assumes the 1.23B ADS-equivalent denominator remains broadly stable; future acquisition accounting, minority-interest adjustments, currency effects, and debt movements could materially change the outcome. The target is a conditional 6-12-month scenario, not a quoted consensus target.
• Conditions and timing for reaching price target: Over the next 6-12 months, the target depends on Q3 2026 and subsequent earnings demonstrating Arbex’s contribution, stabilization of pulp operating margins, and measurable progress on debt reduction.
• Stop Loss: $7.40 ($7.20–$7.60)
• Action trigger upon catalyst achievement:
  • 1 Q3 2026 results demonstrate constructive Arbex consolidation
    • Description: Assess whether tissue EBITDA, margins, and integration expenditures support the expected diversification benefits without excessive debt or working-capital growth. 👉 Maintain Holdings (Hold)
  • 2 Global pulp prices improve alongside shipment recovery
    • Description: Stronger pulp realizations and volumes could support higher normalized EBITDA. Reassess valuation only when the improvement is supported by reported operating results. 👉 Consider Accumulation (Buy)
  • 3 Net leverage declines sustainably
    • Description: Repeated reductions in net debt/adjusted EBITDA would improve financial resilience and support a stronger equity investment case. 👉 Consider Accumulation (Buy)
• Action trigger upon risk realization:
  • 1 Pulp prices and adjusted EBITDA deteriorate for multiple quarters
    • Description: Persistent operating deterioration reduces the likelihood of achieving the normalized earnings scenario. 👉 Reduce Holdings (Sell)
  • 2 Net leverage increases materially above the Q2 2026 baseline
    • Description: Deteriorating debt metrics weaken financial flexibility and reduce the margin of safety. 👉 Reduce Holdings (Sell)
  • 3 Arbex reports weaker-than-expected cash conversion
    • Description: Reassess acquisition economics and financing requirements. If the shortfall remains within the downside operating assumptions, maintain exposure while monitoring subsequent quarters. 👉 Maintain Holdings (Hold)
• Customized Strategy Guide by Investment Preference:
  • Defensive Investors: Favor waiting for sustained debt reduction and stronger free cash flow before initiating or expanding a position. Limit commodity-cycle exposure within the overall portfolio.
  • Neutral Investors: Consider staged purchases inside the defined Buy Zone while monitoring Q3 2026 results, commodity pricing, and leverage.
  • Aggressive Investors: Small, staged positions may offer exposure to a cyclical earnings recovery, but concentration should remain controlled because pulp prices, currency, and financing conditions can change rapidly.

🕵️‍♂️ Deep Dive Analysis

Q1: Is Suzano’s Elevated Leverage Its Biggest Structural Weakness?

• Analysis: Suzano possesses substantial production assets and operating cash generation, but its financial obligations magnify sensitivity to the pulp cycle. The company ended Q2 2026 with USD-based net debt/adjusted EBITDA of 3.4x compared with 3.1x one year earlier. When EBITDA declines, leverage can increase even without substantial new borrowing, reducing flexibility precisely when industry conditions are unfavorable. Continued investment and the Arbex acquisition add complexity to debt reduction.
• Judgment: Negative — Leverage is Suzano’s most important financial vulnerability because it amplifies cyclical earnings risk and can reduce the equity benefits of operational improvement.

Q2: Can Suzano’s 6.49x EV/EBITDA Valuation Be Justified by Its Pulp Cost Advantage and Tissue Expansion?

• Analysis: Suzano trades at a moderate enterprise-value multiple despite its strong production position. The annual historical EV/EBITDA observations from 2021 through 2025 range from 4.54x to 7.68x, placing the current multiple toward the upper part of that sampled range. Cost leadership supports through-cycle competitiveness, but high leverage, depreciation, and reinvestment requirements limit the attractiveness of headline valuation metrics. Arbex may justify improved diversification economics if integration delivers durable cash flow.
• Judgment: Fairly Valued — The enterprise valuation is broadly reasonable, but a more convincing investment discount requires higher sustainable free cash flow or demonstrably lower leverage.

Q3: Can Suzano Turn the Arbex Acquisition Into a Durable Global Tissue Earnings Platform?

• Analysis: Arbex adds substantial international tissue manufacturing and established commercial reach. Its historical pro forma revenue and EBITDA indicate an economically significant expansion, although consolidation, integration costs, and minority interests complicate translation into Suzano shareholder value. The attractiveness of the acquisition depends on whether tissue earnings provide genuine stability during pulp downturns. Successful integration could gradually improve the quality of consolidated earnings, but the first reporting periods must establish actual profitability and capital requirements.
• Judgment: Cautiously Positive — Arbex provides a credible diversification opportunity, though its contribution to per-share value remains conditional on execution and returns on invested capital.

Q4: Does Suzano’s Eucalyptus Forestry Model Create a Sustainable Global Cost Advantage?

• Analysis: Suzano’s geographic position, eucalyptus-growing expertise, plantation integration, and industrial scale support relatively competitive production economics. These advantages are difficult to replicate quickly because forestry assets require land, biological growth cycles, specialized operations, and long-term investment. However, the cost advantage does not eliminate global market pricing pressure. During prolonged downturns, low-cost producers may remain profitable while still experiencing significant declines in margins and return on capital.
• Judgment: Positive — Forestry integration creates a durable cost advantage, but its value is expressed through relative resilience rather than complete insulation from commodity cycles.

Q5: Could New Global Pulp Capacity Undermine Suzano’s Earnings Recovery?

• Analysis: Industrial pulp projects have long development cycles and can introduce large volumes of new supply when commissioned. If incremental output coincides with slower consumption growth or high inventories, benchmark pulp prices can weaken. Suzano’s own production capacity allows substantial operating leverage during recoveries, but the same fixed-cost structure increases earnings sensitivity when realizations decline. The effect depends on competitor operating rates, shutdowns, demand growth, and changes in global inventories.
• Judgment: Negative — Industry oversupply remains a material obstacle to sustained margin recovery, even for a globally competitive producer.

Q6: How Important Is Chinese Demand to Suzano’s Future Earnings?

• Analysis: China is a major destination for globally traded hardwood pulp and influences pricing across international markets. Changes in paper consumption, manufacturing activity, inventories, and domestic pulp production can affect Suzano’s realized export prices. A demand recovery could support both shipments and price realization, while extended weakness could offset improvements in Suzano’s production efficiency. Export-market diversification reduces concentration but does not remove global pricing transmission.
• Judgment: Mixed — Chinese demand creates meaningful cyclical upside potential but also represents an important external earnings risk beyond management’s control.

Q7: Can Suzano Sustain Positive Free Cash Flow After Its Major Investment Cycle?

• Analysis: TTM operating cash flow through June 2026 was approximately BRL 16.66B, with capex of approximately BRL 11.67B, leaving standardized FCF near BRL 5.00B. Major completed capacity projects may reduce future expansion spending, creating an opportunity for stronger free cash flow even without dramatic revenue growth. However, maintenance requirements remain substantial, and Arbex introduces additional investment and working-capital needs. The critical distinction is between a temporary decline in construction spending and a durable increase in distributable cash.
• Judgment: Cautiously Positive — Lower investment intensity offers a plausible cash-flow improvement path, but recurring FCF must be demonstrated across multiple quarters.

Q8: Does Suzano’s Foreign Exchange Exposure Help or Hurt Shareholders?

• Analysis: Suzano earns significant revenue from exports priced directly or indirectly in USD while maintaining substantial BRL-denominated operating costs. A weaker BRL can improve translated export revenue and margins, but foreign-currency liabilities, financial instruments, and hedges can create offsetting effects. Reported net income may therefore change sharply without a comparable change in underlying operating competitiveness. For USD-based ADS investors, currency movements also influence the translated value of the Brazilian business.
• Judgment: Mixed — Currency exposure can enhance operating margins in favorable conditions but introduces substantial financial and equity valuation volatility.

Q9: Can Suzano’s Dividend Become More Attractive as Leverage Declines?

• Analysis: Suzano has a history of dividend distributions, but the current indicated yield of approximately 2.09% is not sufficient by itself to define a dependable income investment. Cash allocation must balance forestry and mill maintenance, debt service, capital spending, and shareholder distributions. If leverage declines while recurring free cash flow rises, dividend capacity may improve. Conversely, prolonged pulp weakness could make debt reduction preferable to larger distributions.
• Judgment: Neutral — Dividend expansion is possible over time, but sustainable cash generation and balance-sheet improvement should take priority over the current yield.

Q10: What Would Make Suzano a More Compelling Long-Term Investment in 2027?

• Analysis: The strongest improvement scenario combines normalized pulp prices, greater utilization of existing production capacity, identifiable Arbex earnings contributions, and lower consolidated leverage. These developments would increase confidence that industrial scale is translating into shareholder-level free cash flow rather than only revenue and EBITDA growth. Investors should monitor company-reported debt ratios, cash spending, adjusted EBITDA per tonne, and incremental returns on the tissue investment. A sustained improvement in these metrics would support a stronger valuation argument than a simple rebound in commodity prices alone.
• Judgment: Constructive but Conditional — Suzano could become a more attractive cyclical investment if operating cash flow strengthens and financial leverage declines consistently without requiring another major investment cycle.